BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34864817)

  • 1. Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT.
    Zheng Y; Li P; Huang H; Ye X; Chen W; Xu G; Zhang F
    Cell Death Discov; 2021 Dec; 7(1):373. PubMed ID: 34864817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT.
    Sun J; Xu Z; Lv H; Wang Y; Wang L; Ni Y; Wang X; Hu C; Chen S; Teng F; Chen W; Cheng X
    Am J Transl Res; 2018; 10(12):4269-4279. PubMed ID: 30662669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
    Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
    Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.
    Zhu ML; Kyprianou N
    FASEB J; 2010 Mar; 24(3):769-77. PubMed ID: 19901020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.
    Bao Y; Lu Y; Wang X; Feng W; Sun X; Guo H; Tang C; Zhang X; Shi Q; Yu H
    Cancer Cell Int; 2015; 15():109. PubMed ID: 26581310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.
    Tang DJ; Dong SS; Ma NF; Xie D; Chen L; Fu L; Lau SH; Li Y; Li Y; Guan XY
    Hepatology; 2010 Apr; 51(4):1255-63. PubMed ID: 20112425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
    Colditz J; Rupf B; Maiwald C; Baniahmad A
    Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes.
    Kong D; Sethi S; Li Y; Chen W; Sakr WA; Heath E; Sarkar FH
    Prostate; 2015 Feb; 75(2):161-74. PubMed ID: 25307492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells.
    Chen C; Zhang B; Wu S; Song Y; Li J
    Oncol Lett; 2018 Apr; 15(4):4541-4549. PubMed ID: 29541224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of RGS2 and Slug in the Androgen-induced Acquisition of Mesenchymal Features of Breast MDA-MB-453 Cancer Cells.
    Alsafadi DB; Abdullah MS; Bawadi R; Ahram M
    Endocr Res; 2022; 47(2):64-79. PubMed ID: 35168462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway.
    Zhao G; Zhang W; Dong P; Watari H; Guo Y; Pfeffer LM; Tigyi G; Yue J
    Cell Biosci; 2021 Apr; 11(1):70. PubMed ID: 33827661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
    Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.
    Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX
    PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic translation initiation factor 5A2 is highly expressed in prostate cancer and predicts poor prognosis.
    Lu J; Zhao HW; Chen Y; Wei JH; Chen ZH; Feng ZH; Huang Y; Chen W; Luo JH; Fang Y
    Exp Ther Med; 2019 May; 17(5):3741-3747. PubMed ID: 30988760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human].
    Meng QB; Yu JC; Kang WM; Ma ZQ; Zhou L; Ye X; Cao ZJ; Tian SB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):482-7. PubMed ID: 25360644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.